#What You Need To Know
Nu Skin Enterprises concluded 2024 with mixed financial results, achieving revenue slightly above guidance but grappling with challenges like diminishing customer engagement, currency fluctuations, and economic difficulties in key areas.
The company reported Q4 revenue of $445.6 million, marking an 8.8% year-over-year decline, primarily driven by foreign exchange losses. Consequently, the adjusted earnings per share were $0.38, while the reported EPS reflected a loss of $0.73 due to ongoing restructuring costs.
Nu Skin is executing a multi-phase transformation aimed at stabilizing revenue and driving operational efficiency. While the company’s sequential growth and restructuring progress are encouraging, weakness in core sales channels remains a challenge. Investors should focus on customer engagement trends, new product adoption, and execution of the 2025 strategy to assess the company’s long-term growth potential.
Nu Skin Enterprises, a global leader in the beauty and wellness industry, operates in nearly 50 markets worldwide. The company provides a broad portfolio of personal care, nutrition, and anti-aging products, backed by 40 years of scientific research. NUS stock is up in pre-market trading.
Sign up for Investing Intel Newsletter
Get the latest news and updates from our team.
#Why This Is Important for Retail Investors
Resilience Amid Challenges – Revenue exceeded company guidance, showing effective cost management and restructuring progress.
Profitability Improvements – Restructuring is driving sequential revenue growth and higher adjusted earnings.
Growth Opportunities – New product launches and expansion in Latin America could offset market declines.
Turnaround Potential – Valuation may be undervalued, with restructuring and innovation supporting future growth.
#Relevant ETFs
Some investors prefer to invest in stocks via an exchange-traded fund for ease and reduced risk. Some relevant ETFs include the following:
SPDR S&P 500 ETF Trust
Invesco QQQ Trust
iShares Russell 2000 ETF
Vanguard Total Stock Market ETF
iShares MSCI EAFE ETF
Vanguard FTSE Emerging Markets ETF